Cargando…

Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021

Newborn screening (NBS) programs identify newborns at increased risk for genetic disorders, linking these newborns to timely intervention and potentially life-saving treatment. In the United States, the Health and Human Services (HHS) Advisory Committee on Heritable Disorders in Newborns and Childre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hale, Kshea, Ojodu, Jelili, Singh, Sikha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293186/ https://www.ncbi.nlm.nih.gov/pubmed/34202531 http://dx.doi.org/10.3390/ijns7030033

Ejemplares similares

Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation
por: Hale, Kshea, et al.
Publicado: (2020)

Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
por: Kellar-Guenther, Yvonne, et al.
Publicado: (2020)

Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020
por: Gaviglio, Amy, et al.
Publicado: (2023)

Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010–2018
por: Singh, Sikha, et al.
Publicado: (2023)

Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States
por: Edelman, Sari, et al.
Publicado: (2020)

Development of National Newborn Screening Quality Indicators in the United States
por: Yusuf, Careema, et al.
Publicado: (2019)

Establishing a National Community of Practice for Newborn Screening Follow-Up
por: Darby, Erin, et al.
Publicado: (2021)

The Landscape of Severe Combined Immunodeficiency Newborn Screening in the United States in 2020: A Review of Screening Methodologies and Targets, Communication Pathways, and Long-Term Follow-Up Practices
por: Sheller, Ruthanne, et al.
Publicado: (2020)

Analyzing Patterns in NewSTEPs Site Review Recommendations: Practical Applications for Newborn Screening Programs
por: Kellar-Guenther, Yvonne, et al.
Publicado: (2019)

Spinal Muscular Atrophy Diagnosed by Newborn Screening
por: Lopez-Chacon, Matias, et al.
Publicado: (2019)

Newborn Screening Practices for Beta-Thalassemia in the United States
por: Bender, Michael A., et al.
Publicado: (2021)

NewSTEPs: The Establishment of a National Newborn Screening Technical Assistance Resource Center
por: Ojodu, Jelili, et al.
Publicado: (2017)

Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017
por: Sontag, Marci K., et al.
Publicado: (2020)

Interventions for spinal muscular atrophy: an impetus for newborn screening
Publicado: (2021)

COVID-19 Pandemic-Related Impacts on Newborn Screening Public Health Surveillance
por: Singh, Sikha, et al.
Publicado: (2022)

Massachusetts’ Findings from Statewide Newborn Screening for Spinal Muscular Atrophy
por: Hale, Jaime E., et al.
Publicado: (2021)

Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy
por: Jędrzejowska, Maria
Publicado: (2020)

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
por: Kimizu, Tomokazu, et al.
Publicado: (2021)

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
por: Weidlich, Diana, et al.
Publicado: (2023)

Newborn screening for spinal muscular atrophy: The views of affected families and adults
por: Boardman, Felicity K., et al.
Publicado: (2017)

Views of the General Population on Newborn Screening for Spinal Muscular Atrophy in Japan
por: Lee, Tomoko, et al.
Publicado: (2021)

Newborn screening for spinal muscular atrophy in Japan: One year of experience
por: Sawada, Takaaki, et al.
Publicado: (2022)

Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository
por: Sontag, Marci K., et al.
Publicado: (2020)

Newborn Screening Practices and Alpha-Thalassemia Detection — United States, 2016
por: Bender, M.A., et al.
Publicado: (2020)

Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population
por: Boardman, Felicity K., et al.
Publicado: (2017)

Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
por: Glascock, Jacqueline, et al.
Publicado: (2018)

Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry
por: Lin, Yiming, et al.
Publicado: (2019)

A call to introduce newborn screening for spinal muscular atrophy (SMA) in Scotland
por: Gillingwater, Thomas H., et al.
Publicado: (2022)

Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
por: Pane, Marika, et al.
Publicado: (2022)

2023 APHL/ISNS Newborn Screening Symposium
por: Olney, Richard S., et al.
Publicado: (2023)

Actions in Support of Newborn Screening for Critical Congenital Heart Disease — United States, 2011–2018
por: Glidewell, Jill, et al.
Publicado: (2019)

A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study
por: Shinohara, Masakazu, et al.
Publicado: (2019)

Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
por: Vill, Katharina, et al.
Publicado: (2021)

Technical feasibility of newborn screening for spinal muscular atrophy by next-generation DNA sequencing
por: Shum, Bennett O. V., et al.
Publicado: (2023)

PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan
por: Noguchi, Yoriko, et al.
Publicado: (2022)

Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation
por: Mikhalchuk, Kristina, et al.
Publicado: (2023)

Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
por: Aragon-Gawinska, Karolina, et al.
Publicado: (2023)

Case Definitions for Conditions Identified by Newborn Screening Public Health Surveillance
por: Sontag, Marci K., et al.
Publicado: (2018)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme
por: D'Silva, Arlene M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7r41mcuq26b4qsq4na8foiq9q7